Provider: Thomson Reuters Stock Report
Human Metabolome Technologies Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Human Metabolome Technologies to receive subsidy from NEDO
Human Metabolome Technologies Inc:To receive subsidy up to 75,143,000 yen from New Energy and Industrial Technology Development Organization (NEDO), for development of clinical test kit using blood biomarker for liver patient, until Feb. 28, 2015.
Latest Developments for Human Metabolome Technologies Inc
- Human Metabolome Technologies Inc amends consolidated mid-year outlook for FY 2015
- Human Metabolome Technologies Inc amends consolidated full-year outlook for FY 2015
- Human Metabolome Technologies Inc lowers consolidated full-year outlook for FY 2014
- Human Metabolome Technologies Inc gives consolidated full-year forecast for FY 2014
Latest Key Developments in Biotechnology
- Foamix Ltd announces closing of initial public offering
- ZS Pharma announces positive top-line results from HARMONIZE
- ProQR Therapeutics BV announces closing of initial public offering and full exercise of underwriters' option to purchase additional shares
- Galmed Pharmaceuticals Ltd announces U.S. FDA approval of fast track designation of aramchol for treatment of NASH
- Share this
- Digg this